This protocol is judged by an institutional review board, an impartial group that evaluations any clinical trials involving humans. If a study requires a Schedule I drug, when the board approves the protocol as ethical, the researchers really have to apply for an investigational new drug (IND) variety from your FDA.Lots of social media marketing o